These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7903326

  • 1. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder.
    Boyer WF, Feighner JP.
    Int Clin Psychopharmacol; 1993; 8(3):173-6. PubMed ID: 7903326
    [Abstract] [Full Text] [Related]

  • 2. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR, Hesselink JM, Sramek JJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL, Albrecht JW, Diamond BI.
    Psychopharmacol Bull; 1990 May; 26(2):207-10. PubMed ID: 1978371
    [Abstract] [Full Text] [Related]

  • 4. A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression.
    Lapierre YD, Silverstone P, Reesal RT, Saxena B, Turner P, Bakish D, Plamondon J, Vincent PM, Remick RA, Kroft C, Payeur R, Rosales D, Lam R, Bologa M.
    J Clin Psychopharmacol; 1998 Aug; 18(4):268-73. PubMed ID: 9690691
    [Abstract] [Full Text] [Related]

  • 5. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993 Aug; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 7. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R, Beaudry P, Beauclair L, Chouinard G.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Dec; 11(2-3):189-97. PubMed ID: 2888159
    [Abstract] [Full Text] [Related]

  • 8. Buspirone and diazepam in anxiety: a controlled study.
    Rickels K, Weisman K, Norstad N, Singer M, Stoltz D, Brown A, Danton J.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078
    [Abstract] [Full Text] [Related]

  • 9. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K, Schweizer E, DeMartinis N, Mandos L, Mercer C.
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
    Feighner JP, Merideth CH, Hendrickson GA.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066
    [Abstract] [Full Text] [Related]

  • 12. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [Abstract] [Full Text] [Related]

  • 13. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF, Goldstein BJ, Dominguez RA, Steinbook RM.
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [Abstract] [Full Text] [Related]

  • 14. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
    Berlin I, Warot D, Legout V, Guillemant S, Schöllnhammer G, Puech AJ.
    Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
    [Abstract] [Full Text] [Related]

  • 15. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.
    Ansseau M, Olié JP, von Frenckell R, Jourdain G, Stehle B, Guillet P.
    Psychopharmacology (Berl); 1991 Apr; 104(4):439-43. PubMed ID: 1685793
    [Abstract] [Full Text] [Related]

  • 16. Buspirone: multicenter efficacy study.
    Wheatley D.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [Abstract] [Full Text] [Related]

  • 17. Review of the side-effect profile of buspirone.
    Newton RE, Marunycz JD, Alderdice MT, Napoliello MJ.
    Am J Med; 1986 Mar 31; 80(3B):17-21. PubMed ID: 2870641
    [Abstract] [Full Text] [Related]

  • 18. Buspirone: anxiolytic?
    Pecknold JC, Familamiri P, Chang H, Wilson R, Alarcia J, McClure DJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Mar 31; 9(5-6):639-42. PubMed ID: 2868495
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T, Riedel WJ, van Praag HM, Menheere PP, Griez E.
    Psychiatry Res; 2002 Dec 15; 113(1-2):29-40. PubMed ID: 12467943
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder.
    Czobor P, Skolnick P, Beer B, Lippa A.
    CNS Neurosci Ther; 2010 Apr 15; 16(2):63-75. PubMed ID: 20041911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.